Tumor Progression
|
0.100 |
AlteredExpression
|
phenotype |
BEFREE |
The gene for the secreted integrin-binding protein osteopontin was most consistently differentially expressed in conjunction with tumor progression.
|
11929952 |
2002 |
Tumor Progression
|
0.100 |
AlteredExpression
|
phenotype |
BEFREE |
These results suggest that the presence of these transcription factors in human breast cancer is responsible in part for the overexpression of OPN that, in turn, is implicated in mammary neoplastic progression and metastasis.
|
14990565 |
2004 |
Tumor Progression
|
0.100 |
AlteredExpression
|
phenotype |
BEFREE |
While constitutive expression of OPN exists in several cell types, induced expression has been detected in T-lymphocytes, epidermal cells, bone cells, macrophages, and tumor cells in remodeling processes such as inflammation, ischemia-reperfusion, bone resorption, and tumor progression.
|
15501463 |
2004 |
Tumor Progression
|
0.100 |
Biomarker
|
phenotype |
BEFREE |
Osteopontin (OPN) is a multifunctional bone matrix glycoprotein that is involved in angiogenesis, cell survival and tumor progression.
|
16208410 |
2005 |
Tumor Progression
|
0.100 |
AlteredExpression
|
phenotype |
BEFREE |
This study provides the first evidence that OPN can lead to numerous gene expression changes that influence multiple aspects of tumor progression and malignant growth.
|
15864800 |
2005 |
Tumor Progression
|
0.100 |
Biomarker
|
phenotype |
BEFREE |
This study aimed to elucidate the interaction of the frequent aberrant mRNA expression of alpha-fetoprotein (AFP), osteopontin (OPN) and a novel short isoform of annexin A10 (ANXA10S) at 4q in the tumor progression among 294 patients who received surgical resection of unifocal primary HCC.
|
15754002 |
2005 |
Tumor Progression
|
0.100 |
GeneticVariation
|
phenotype |
BEFREE |
Stathmin overexpression cooperates with p53 mutation and osteopontin overexpression, and is associated with tumour progression, early recurrence, and poor prognosis in hepatocellular carcinoma.
|
16739096 |
2006 |
Tumor Progression
|
0.100 |
Biomarker
|
phenotype |
BEFREE |
OPN is a cytokine and cell attachment protein which has been implicated in human tumor progression and metastasis, the calcium binding 126MRP protein is related to the human S100 protein family involved in invasive cell growth, and the Rac2 protein belongs to the Rho family of small GTPases regulating actin reorganization and cell migration.
|
16491116 |
2006 |
Tumor Progression
|
0.100 |
Biomarker
|
phenotype |
BEFREE |
Research concerning how OPN functions in tumor progression has led to the identification of a limited number of genes that contribute functionally to OPN-induced cellular behaviors.
|
16807238 |
2006 |
Tumor Progression
|
0.100 |
Biomarker
|
phenotype |
BEFREE |
SPP1 is not necessary for tumor progression in osteosarcoma and may be associated with inflammatory response and bone remodeling, functioning as a good biomarker.
|
17022822 |
2006 |
Tumor Progression
|
0.100 |
Biomarker
|
phenotype |
BEFREE |
Thus, in addition to the widely reported roles of OPN in late stages of tumor progression, these results provide functional evidence that OPN contributes to breast tumor growth as well.
|
16830223 |
2006 |
Tumor Progression
|
0.100 |
Biomarker
|
phenotype |
BEFREE |
We have shown that osteopontin stimulates the activation of protein kinase C alpha/nuclear factor-inducing kinase/nuclear factor-kappaB-dependent signaling cascades that induces COX-2 expression, which in turn regulates the prostaglandin E(2) production, matrix metalloproteinase-2 activation, and tumor progression and angiogenesis.
|
16818637 |
2006 |
Tumor Progression
|
0.100 |
AlteredExpression
|
phenotype |
BEFREE |
Recent clinical studies have indicated that OPN expression is associated with tumor progression and poor prognosis among patients with lung cancer.
|
17482311 |
2007 |
Tumor Progression
|
0.100 |
Biomarker
|
phenotype |
BEFREE |
Osteopontin (OPN), a secreted phosphoglycoprotein, has been strongly associated with tumor progression and aggressive cancers.
|
17227585 |
2007 |
Tumor Progression
|
0.100 |
Biomarker
|
phenotype |
BEFREE |
The role of osteopontin in tumor progression and metastasis in breast cancer.
|
17548669 |
2007 |
Tumor Progression
|
0.100 |
Biomarker
|
phenotype |
BEFREE |
Osteopontin (OPN) is a secreted phosphoprotein, which has been reported to be associated with tumor progression in numerous solid tumors.
|
17565744 |
2007 |
Tumor Progression
|
0.100 |
Biomarker
|
phenotype |
BEFREE |
Osteopontin (OPN) plays important roles in tumor progression and metastasis through binding to OPN receptors such as alpha(v)beta(beta) integrin and CD44, and its overexpression in tumor is associated poor clinical outcome of NSCLC patients.
|
17513004 |
2007 |
Tumor Progression
|
0.100 |
Biomarker
|
phenotype |
BEFREE |
The family of glycophosphoproteins comprising osteopontin, bone sialoprotein, dentin matrix protein 1, dentin sialophosphoprotein and matrix extracellular phosphoglycoprotein - small integrin-binding ligand N-linked glycoproteins (SIBLINGs) - are emerging as important players in many stages of cancer progression.
|
18292776 |
2008 |
Tumor Progression
|
0.100 |
Biomarker
|
phenotype |
BEFREE |
An increasing number of studies have shown that OPN plays an important role in controlling cancer progression and metastasis.
|
17952379 |
2008 |
Tumor Progression
|
0.100 |
Biomarker
|
phenotype |
BEFREE |
Finally, we show that OPN is expressed in senescent stroma within preneoplastic lesions that arise following 7,12-dimethylbenz(a)anthracene/12-O-tetradecanoylphorbol-13-acetate treatment of mice, suggesting that stromal-derived OPN-mediated signaling events affect neoplastic progression.
|
19155301 |
2009 |
Tumor Progression
|
0.100 |
AlteredExpression
|
phenotype |
BEFREE |
Conversely, treatment also increased transcription of OPN that may be implicated in tumor progression.
|
19184984 |
2009 |
Tumor Progression
|
0.100 |
Biomarker
|
phenotype |
BEFREE |
BRMS1 forms complexes with SIN3, histone deacetylases and selected transcription factors that modify metastasis-associated gene expression (e.g., EGFR, OPN, PI4P5K1A, PLAU). microRNA (miRNA) are a recently discovered class of regulatory, noncoding RNA, some of which are involved in neoplastic progression.
|
19585508 |
2009 |
Tumor Progression
|
0.100 |
AlteredExpression
|
phenotype |
BEFREE |
NR4A2 levels were increased throughout tumor progression in Apc(Delta14/+) mice but, unlike osteopontin, did not correlate with tumor stage.
|
19549529 |
2009 |
Tumor Progression
|
0.100 |
Biomarker
|
phenotype |
BEFREE |
Here, we use genetic approaches to systematically investigate the function of the RGD domain in different OPN isoforms on tumor progression and metastasis for 2 different solid tumor models.
|
20224789 |
2010 |
Tumor Progression
|
0.100 |
Biomarker
|
phenotype |
BEFREE |
Osteopontin is a secreted, integrin-binding and phosphorylated acidic glycoprotein, which has an important role in tumour progression.
|
19901966 |
2010 |